Why the study?
To analyze the pathogenesis of atrial fibrillation in patients with arterial hypertension and evaluate optimal treatment tactics, prevention, and management of thromboembolic complications.
Answers are grounded in this paper and cite their sources.
This review summarizes the current understanding of the pathogenesis, diagnosis, and treatment of atrial fibrillation in patients with arterial hypertension.
The present literature review is devoted to the analysis of the features of the pathogenesis of atrial fibrillation in patients with arterial hypertension and to the optimal treatment tactics in this cohort of patients. In particular, pathological mechanisms (hemodynamic, structural, and electrophysiological) of the development of atrial fibrillation in arterial hypertension are reviewed. The article highlights the problems of primary and secondary prevention of atrial fibrillation using antihypertensive therapy as well as the aspects of the prevention of thromboembolic complications in patients with atrial fibrillation and arterial hypertension.
No takes yet. Share an insight, caveat, or question.
Kirgizova et al. (2019) conducted a review in Atrial fibrillation and arterial hypertension. Antihypertensive therapy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: